Closing a heart tube to improve heart function
Part of Heart & circulation clinical trials.
This trial tests a procedure that closes a small heart tube (called the ductus arteriosus) that stays open after birth. The goal is to see if closing it helps the heart work better in teens and adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years old or older.
- You have a ductus arteriosus that can be closed with a catheter (a thin tube inserted through a blood vessel).
- The ductus arteriosus is not silent (meaning your doctor can hear it with a stethoscope).
- You do not have severe, irreversible lung problems from the ductus arteriosus.
- You do not have an active infection or heart infection.
- You are willing to take part in the study.
- You do not have diabetes, high blood pressure, or heart artery disease.
- You do not have other heart defects that could affect the heart's pumping function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a procedure called transcatheter closure works for children with Patent Ductus Arteriosus (PDA), a small extra blood vessel in the heart that should close after birth. The procedure uses a thin tube (catheter) to close the vessel without open surgery, and researchers want to see how children do over a 3-year period.
This trial creates a registry to gather information on premature babies who have a PDA (an open blood vessel in the heart) and are getting it closed with a catheter-based device. It helps doctors learn more about how safe and effective this treatment is for these tiny babies.
This trial compares an early procedure to close a heart vessel called the ductus arteriosus versus careful observation alone in very low-birth-weight preterm infants. It aims to see whether closing the vessel early can improve outcomes and be done safely.
This study checks how well and how safely the Occlutech PDA Occluder works over time to close a patent ductus arteriosus (PDA). You may be considered if your PDA can be treated with this non-surgical device and you can return for follow-up visits.
This study tests a personalized approach to treating a common heart condition in very early preterm babies, where a blood vessel (the ductus arteriosus) stays open. It aims to find the best time and way to close this vessel using medication, based on the baby's specific biomarkers.
This study follows patients who had a small heart device (HeartR PDA Occluder) placed to close an opening in their heart called a PDA. Researchers will check how well the device is working and track the patient's health over time.
Hear when a new Patent Ductus Arterioses trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.